VISIT OUR VIRTUAL BOOTH
- At uniQure, we are currently conducting an early phase clinical trial to investigate a new potential gene therapy for patients with Huntington’s disease.
- uniQure is leveraging more than 20 years of experience in gene therapy to develop treatments for rare genetic diseases including Huntington’s disease.
Read more about AMT-130
Visit us at:
- Twitter: @uniQure_NV
- LinkedIn: https://www.linkedin.com/company/uniqure